Correlation Between Grupo Aval and Fusion Pharm
Can any of the company-specific risk be diversified away by investing in both Grupo Aval and Fusion Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Grupo Aval and Fusion Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Grupo Aval and Fusion Pharm, you can compare the effects of market volatilities on Grupo Aval and Fusion Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Grupo Aval with a short position of Fusion Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Grupo Aval and Fusion Pharm.
Diversification Opportunities for Grupo Aval and Fusion Pharm
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Grupo and Fusion is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Grupo Aval and Fusion Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fusion Pharm and Grupo Aval is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Grupo Aval are associated (or correlated) with Fusion Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fusion Pharm has no effect on the direction of Grupo Aval i.e., Grupo Aval and Fusion Pharm go up and down completely randomly.
Pair Corralation between Grupo Aval and Fusion Pharm
Given the investment horizon of 90 days Grupo Aval is expected to generate 0.72 times more return on investment than Fusion Pharm. However, Grupo Aval is 1.38 times less risky than Fusion Pharm. It trades about 0.0 of its potential returns per unit of risk. Fusion Pharm is currently generating about -0.05 per unit of risk. If you would invest 235.00 in Grupo Aval on September 12, 2024 and sell it today you would lose (21.00) from holding Grupo Aval or give up 8.94% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Grupo Aval vs. Fusion Pharm
Performance |
Timeline |
Grupo Aval |
Fusion Pharm |
Grupo Aval and Fusion Pharm Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Grupo Aval and Fusion Pharm
The main advantage of trading using opposite Grupo Aval and Fusion Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Grupo Aval position performs unexpectedly, Fusion Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fusion Pharm will offset losses from the drop in Fusion Pharm's long position.Grupo Aval vs. JPMorgan Chase Co | Grupo Aval vs. Citigroup | Grupo Aval vs. Wells Fargo | Grupo Aval vs. Toronto Dominion Bank |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |